[go: up one dir, main page]

AU2002230390A1 - Ixodes scapularis tissue factor pathway inhibitor - Google Patents

Ixodes scapularis tissue factor pathway inhibitor

Info

Publication number
AU2002230390A1
AU2002230390A1 AU2002230390A AU3039002A AU2002230390A1 AU 2002230390 A1 AU2002230390 A1 AU 2002230390A1 AU 2002230390 A AU2002230390 A AU 2002230390A AU 3039002 A AU3039002 A AU 3039002A AU 2002230390 A1 AU2002230390 A1 AU 2002230390A1
Authority
AU
Australia
Prior art keywords
tissue factor
pathway inhibitor
factor pathway
ixodes scapularis
scapularis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002230390A
Inventor
Ivo M.B. Francischetti
Jose M. Ribeiro
Jesus G. Valenzuela
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU2002230390A1 publication Critical patent/AU2002230390A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002230390A 2000-10-05 2001-10-05 Ixodes scapularis tissue factor pathway inhibitor Abandoned AU2002230390A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24057500P 2000-10-05 2000-10-05
US60/240,575 2000-10-05
PCT/US2001/042472 WO2002033089A2 (en) 2000-10-05 2001-10-05 Ixodes scapularis tissue factor pathway inhibitor

Publications (1)

Publication Number Publication Date
AU2002230390A1 true AU2002230390A1 (en) 2002-04-29

Family

ID=22907098

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002230390A Abandoned AU2002230390A1 (en) 2000-10-05 2001-10-05 Ixodes scapularis tissue factor pathway inhibitor

Country Status (3)

Country Link
US (1) US7078508B2 (en)
AU (1) AU2002230390A1 (en)
WO (1) WO2002033089A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7528227B2 (en) * 2004-03-23 2009-05-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Histone H2A peptide derivatives and uses thereof
US20050123554A1 (en) * 2002-04-29 2005-06-09 The Board Of Regents For Oklahoma State University Protective antigens and vaccines for the control of multi species tick infestations
CA2582353A1 (en) * 2004-10-06 2006-04-20 University Of Rochester Treatment of pulmonary hypertension using an agent that inhibits a tissue factor pathway
BRPI0922344A2 (en) 2008-12-19 2017-10-24 3B Pharmaceuticals Gmbh tfpi inhibitors and methods of use
US8772238B2 (en) 2009-03-18 2014-07-08 The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Use of ixolaris, a tissue factor inhibitor, for the treatment of cancer
WO2011115712A2 (en) 2010-03-19 2011-09-22 Baxter International Inc Tfpi inhibitors and methods of use
GB2485590A (en) * 2010-11-22 2012-05-23 Univ Ruprecht Karis Heidelberg Method for detecting at least one direct factor Xa inhibitors
CN104302306B (en) 2012-03-21 2019-03-22 百深有限责任公司 TFPI inhibitors and methods of use
BR112015001628A2 (en) 2012-07-25 2017-11-07 Catalyst Biosciences Inc modified factor x polypeptides and their use
KR101909052B1 (en) * 2017-02-09 2018-10-17 강원대학교산학협력단 Peptide fragments derived from insulin A-chain and pharmaceutical composition for preventing or treating diabetes or diabetic wounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US5453492A (en) * 1993-07-28 1995-09-26 La Jolla Cancer Research Foundation 60 kDa transforming growth factor-β-binding protein and its use to detect or purify TGF-β
US5837458A (en) * 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US5605793A (en) * 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
WO1996039486A1 (en) * 1995-06-05 1996-12-12 Human Genome Sciences, Inc. Human ccn-like growth factor
US6395511B1 (en) * 1998-11-27 2002-05-28 Darwin Discovery, Ltd. Nucleic acids encoding a novel family of TGF-β binding proteins from humans

Also Published As

Publication number Publication date
WO2002033089A2 (en) 2002-04-25
US7078508B2 (en) 2006-07-18
US20040018516A1 (en) 2004-01-29
WO2002033089A3 (en) 2004-02-26

Similar Documents

Publication Publication Date Title
AU2002216311A1 (en) Surgical reamer
AU2001288610A1 (en) Feminine hygiene kit
AU2001229583A1 (en) Bone drill
AU2001258771A1 (en) -secretase inhibitors
AU2001259237A1 (en) Reverse keno
AU7860201A (en) Dermatological composition
AU2002220241A1 (en) Parb inhibitors
AU2001250538A1 (en) Surgical tool
AU2001259702A1 (en) Tissue regrafting
AU2001265662A1 (en) Ergometer
AU2002230390A1 (en) Ixodes scapularis tissue factor pathway inhibitor
AU2001283340A1 (en) Factor viia inhibitors
AU4432001A (en) Trityl-type compounds and their use
AUPQ575300A0 (en) New compound
AUPR099200A0 (en) New formulation
AUPR069500A0 (en) Tissue modification
AU2001277236A1 (en) Shoe construction
EP1126339A3 (en) Stopwatch
AU6286101A (en) New use
AU4487001A (en) Back reamer
AU2001274683A1 (en) Contrast agents
AU2001229209A1 (en) Hydrokeratome for refractive surgery
AU2002224528A1 (en) New use
AU5235701A (en) Sump
AU6759601A (en) Well